About us | Advertise with us | Contact us
Posted: 26 May 2022 | Hannah Balfour (European Pharmaceutical Review) | No comments yet
According to a recent paper, by specifying equipment surface roughness as well as finish, pharmaceutical manufacturers can limit microbial attachment.
In a recent paper, pharmaceutical microbiologist and contamination control expert Tim Sandle explored the critical role surface roughness can play in preventing microbial attachment. Here, EPR summarises the salient points.
Not only do surface roughness and cleanability have a relationship, but the former can also promote or dissuade microbial attachment and adhesion, wrote Sandle. Attachment is the bacteria’s appendages sticking to a surface, where adhesion is when adhesive molecules expressed on the bacterial surface bind to host surface receptors. The latter is associated with biofilm formation.
Because of this relationship, specifying appropriate finishes and limits of roughness should form part of equipment and facility specifications.
Surface roughness, the height variation within a surface, is commonly reported using average roughness (Ra; expressed as µm). While commonly used and accepted by industry as a standard, Ra is limited in that it does not give insight into the distribution or shape of the surface features.
According to Sandle, though stainless steel finish may have an impact on microbial attachment, surface roughness and any potential damage are of greater importance, provided the surface finish is uniform. The grade of the steel is also important, as 316 grade stainless steel has been found to record lower levels of microbial attachment than 304 grade stainless steel when both were exposed to the same conditions.
Not only do rough surfaces wear more quickly, but, according to Sandle, an increased degree of roughness generally leads to an increase in the contact area for a bacterial cell, making microbial attachment easier. That roughness relates to bacterial attachment is a probabilistic concept. A key understanding is that attachment is harder when surfaces have an Ra <0.8µm and attachment becomes easier with an Ra >0.8µm.
Roughness also impacts the ability to clean and disinfect surfaces consistently, as rougher surfaces are more difficult to clean. Research has suggested that surfaces with an Ra between 0.4 to 1.5µm best facilitate cleaning, with cleanability falling away at higher Ra values where long-term microbial attachment occurs.
Other factors that can influence attachment are surface slope, as bacteria generally prefer to attach to horizontal surfaces, that bacteria tend to colonise near welds and surface irregularities.
Surface damage is also a critical consideration, as it will influence the likelihood of microbial adhesion or entrapment. Sandle reports that there is a strong correlation between bacterial adhesion and- damage that increases surface roughness in literature. The type, shape and size of the damage all have a role to play; for instance linear scratches may promote the entrapment of rod shaped bacteria, and abrasions the size of microbes are more likely to promote bacterial retention than much larger ones.
Microorganisms can also cause corrosion and damage of the materials they attach to, which may facilitate future bacterial attachment. Corrosion may also be caused by disinfectants, especially those that are chlorine based.
Sandle concluded that to lower the likelihood of microbial attachment, it is critical to specify surface roughness as well as surface finish in equipment specifications, with an Ra value <0.8µm providing control. He added that down to an Ra value of 0.16µm benefits can be seen, after which anything smoother ceases to be significant.
The full article was published in the Journal of GXP Compliance.
Cleanrooms, Drug Manufacturing, Environmental Monitoring, Lab Equipment, Microbial Detection, Microbiology
Tim Sandle (Bio Products Laboratory)
By Hannah Balfour (European Pharmaceutical Review)
Cleanrooms, Drug Manufacturing, Environmental Monitoring, Lab Equipment, Microbial Detection, Microbiology
Tim Sandle (Bio Products Laboratory)
All subscriptions include online membership, giving you access to the journal and exclusive content.
By Hannah Balfour (European Pharmaceutical Review)
By Hannah Balfour (European Pharmaceutical Review)
By Hannah Balfour (European Pharmaceutical Review)
Your email address will not be published. Required fields are marked *
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Write for us | Advertise with us
European Pharmaceutical Review is published by: Russell Publishing Ltd. Court Lodge Hogtrough Hill Brasted, Kent, TN16 1NU United Kingdom
© Russell Publishing Limited, 2010-2022. All rights reserved.
Website development by e-Motive Media Limited.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
CookieDescriptioncookielawinfo-checkbox-advertising-targetingThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".cookielawinfo-checkbox-analyticsThis cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".cookielawinfo-checkbox-necessaryThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".cookielawinfo-checkbox-performanceThis cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".PHPSESSIDThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.viewed_cookie_policyThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.zmember_loggedThis session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.